These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22858075)

  • 1. Protective effect of carvedilol on adriamycin-induced left ventricular dysfunction in children with acute lymphoblastic leukemia.
    El-Shitany NA; Tolba OA; El-Shanshory MR; El-Hawary EE
    J Card Fail; 2012 Aug; 18(8):607-13. PubMed ID: 22858075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive role of carvedilol in adriamycin-induced cardiomyopathy.
    Jhorawat R; Kumari S; Varma SC; Rohit MK; Narula N; Suri V; Malhotra P; Jain S
    Indian J Med Res; 2016 Nov; 144(5):725-729. PubMed ID: 28361826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carvedilol on silent anthracycline-induced cardiotoxicity assessed by strain imaging: A prospective randomized controlled study with six-month follow-up.
    Elitok A; Oz F; Cizgici AY; Kilic L; Ciftci R; Sen F; Bugra Z; Mercanoglu F; Oncul A; Oflaz H
    Cardiol J; 2014; 21(5):509-15. PubMed ID: 24142687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective Role of Silymarin in Early Doxorubicin-induced Cardiac Dysfunction in Children with Acute Lymphoblastic Leukemia.
    Hagag AA; El Shehaby WA; El-Abasy AI; Mabrouk MM
    Infect Disord Drug Targets; 2019; 19(2):133-140. PubMed ID: 30073931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia.
    Lipshultz SE; Lipsitz SR; Sallan SE; Dalton VM; Mone SM; Gelber RD; Colan SD
    J Clin Oncol; 2005 Apr; 23(12):2629-36. PubMed ID: 15837978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.
    Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L
    Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of carvedilol against anthracycline-induced cardiomyopathy.
    Kalay N; Basar E; Ozdogru I; Er O; Cetinkaya Y; Dogan A; Inanc T; Oguzhan A; Eryol NK; Topsakal R; Ergin A
    J Am Coll Cardiol; 2006 Dec; 48(11):2258-62. PubMed ID: 17161256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of carvedilol on chronic renal failure progression in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Dimitrijevic J; Maksic N; Djukanovic L
    Clin Nephrol; 2005 Jun; 63(6):446-53. PubMed ID: 15960146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy.
    Cheung YF; Hong WJ; Chan GC; Wong SJ; Ha SY
    Heart; 2010 Jul; 96(14):1137-41. PubMed ID: 20511624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective role of black seed oil in doxorubicin-induced cardiac toxicity in children with acute lymphoblastic leukemia.
    Hagag AA; Badraia IM; El-Shehaby WA; Mabrouk MM
    J Oncol Pharm Pract; 2020 Sep; 26(6):1397-1406. PubMed ID: 31964219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of dilated cardiomyopathy with carvedilol in children.
    Erdoğan I; Ozer S; Karagöz T; Celiker A; Ozkutlu S; Alehan D
    Turk J Pediatr; 2009; 51(4):354-60. PubMed ID: 19950843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol as a protector against the cardiotoxicity induced by anthracyclines (doxorubicin).
    Machado V; Cabral A; Monteiro P; Gonçalves L; Providência LA
    Rev Port Cardiol; 2008 Oct; 27(10):1277-96. PubMed ID: 19178029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol prevents and reverses hypertrophy-induced cardiac dysfunction.
    Barone FC; Willette RN; Nelson AH; Ohlstein EH; Brooks DP; Coatney RW
    Pharmacology; 2007; 80(2-3):166-76. PubMed ID: 17551266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enalapril and carvedilol for preventing chemotherapy-induced left ventricular systolic dysfunction in patients with malignant hemopathies: the OVERCOME trial (preventiOn of left Ventricular dysfunction with Enalapril and caRvedilol in patients submitted to intensive ChemOtherapy for the treatment of Malignant hEmopathies).
    Bosch X; Rovira M; Sitges M; Domènech A; Ortiz-Pérez JT; de Caralt TM; Morales-Ruiz M; Perea RJ; Monzó M; Esteve J
    J Am Coll Cardiol; 2013 Jun; 61(23):2355-62. PubMed ID: 23583763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silymarin prevents adriamycin-induced cardiotoxicity and nephrotoxicity in rats.
    El-Shitany NA; El-Haggar S; El-desoky K
    Food Chem Toxicol; 2008 Jul; 46(7):2422-8. PubMed ID: 18487002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
    Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of natriuretic peptides in relation to doxorubicin-induced cardiotoxicity and cardiac function in children with cancer.
    Hayakawa H; Komada Y; Hirayama M; Hori H; Ito M; Sakurai M
    Med Pediatr Oncol; 2001 Jul; 37(1):4-9. PubMed ID: 11466716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy.
    Doughty RN; Whalley GA; Walsh HA; Gamble GD; López-Sendón J; Sharpe N;
    Circulation; 2004 Jan; 109(2):201-6. PubMed ID: 14707020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
    Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
    Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.